My point, which I should have stated instead of assuming the reader would make the connection, is that they are giving the new, more costly drug, preference over the partially proven cheap drug with political overtones.
i got your point. The be point I am making is while everyone is focused on the cheap drug it is not a miracle or necessarily the best treatment. It is an arrow in the quiver but real studies are being done and finding encouraging results in treating critical patients. They are looking better than the cheaper alternative which doesn’t appear to have much to offer hosptalized patients. The ones not in the hospital do fine anyway so we need to see if it’s worth the risk of exposing them to a drug with side effects to treat something they will get over in their own anyway. I don’t know the answer to that yet.